Abstract
In response to ever increasing health-care cost pressures, governments and health-care organizations around the globe are experimenting with various cost containment methods, including the use of tendering for medical devices. Although this procurement process has proven to increase buyer power and drive down procurement prices, it has struggled to reduce overall health-care spending and has contributed to unintended negative consequences affecting patient access and competition. Our research included an in-depth review of available research across 10 countries and interviews with government officials, caregivers and medical device industry leaders. Research findings reveal five keys to establishing objective, efficient and flexible medical technology procurement strategies that will help prevent negative consequences in the future.
Get full access to this article
View all access options for this article.
